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A B S T R A C T
Background: Extracellular vesicles (EVs) represent a plausible molecular mechanism linking particulate matter
(PM) inhalation to its systemic eﬀects. Microvesicles (MVs) are released from many cell types in response to
various stimuli. Increased body mass index (BMI) could modify the response to PM exposure due to enhanced
PM uptake and/or an underlying pro-oxidative state.
We investigated the relationship between EV release and PM10/PM2.5 exposure in a cohort of 51 volunteers.
Subjects were stratiﬁed based on their BMI to evaluate whether overweight BMI is a determinant of
hypersusceptibility to PM eﬀects.
Results: Exposure to PM10/PM2.5 was assessed with a personal sampler worn for 24 hours before plasma
collection and conﬁrmed with monitoring station data. Size and cellular origin of plasma EVs were characterized
by Nanosight analysis and ﬂow cytometry, respectively. Multivariate regression models were run after log-
transformation, stratifying subjects based on BMI (≥ or < 25 kg/m2).
PM exposure resulted in increased release of EVs, with the maximum observed eﬀect for endothelial MVs.
For PM10 and PM2.5, the adjusted geometric mean ratio and 95% conﬁdence interval were 3.47 (1.30, 9.27) and
3.14 (1.23, 8.02), respectively. Compared to those in normal subjects, PM-induced EV alterations in overweight
subjects were more pronounced, with visibly eﬀect in all MV subtypes, particularly endothelial MVs.
Conclusions: Our ﬁndings emphasize the role of EV release after PM exposure and the susceptibility of
overweight subjects. Larger studies with accurate exposure assessment and complete EVs characterization/
content analysis, could further clarify the molecular mechanism responsible for PM eﬀects and of hypersuscept-
ibility of overweight subjects.
1. Introduction
Numerous epidemiological studies have shown that short-term
exposure to particulate matter (PM) air pollution is associated with
increased morbidity and mortality, primarily from cardiovascular
disease (CVD) (Katsouyanni et al., 2001; Kinney and Ozkaynak,
1991; Schwartz and Dockery, 1992). Despite this consistently observed
association between air pollution and sistemic eﬀects, the underlying
molecular mechanism responsible for this relationship is still poorly
understood. It has been proposed that ambient particles trigger
pulmonary oxidative stress and inﬂammatory responses that lead to
the release of molecular signals into the circulatory system (Bollati
et al., 2015). Determining the identity of these signals that link PM
inhalation to systemic inﬂammation and endothelial response has been
considered a high priority objective, in order to better understand
possible pathway involved in determining the observed increase in
CVD risk.
Recently, extracellular vesicles (EVs) have gained increasing con-
sideration as a very plausible link. EVs represent a novel means for
intercellular and between-tissue communication (Raposo and
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Stoorvogel, 2013), as they can travel from the tissue of origin to target
cells and transfer their contents after being internalized (Hunter et al.,
2008). These EVs are small ( < 1.0 µm) plasma membrane fragments
that accumulate in biological ﬂuids. Studies have shown that they play
an important role in a variety of biological and pathological processes
(Johnson et al., 2014), including atherosclerosis (Leroyer et al., 2008),
thrombosis (Rautou et al., 2011), rheumatoid arthritis (Jungel et al.,
2007), cancer (Jungel et al., 2007), and inﬂammation and sepsis
(Prakash et al., 2012). Based on their size, they can be classiﬁed as
exosomes (30–130 nm) and microvesicles (MVs, 130–700 nm).
Exosomes are thought to be constitutively generated, stored, and
released from the endosomal system, whereas MVs are shed from the
plasma membrane in response to speciﬁc stimuli (Larson et al., 2014).
MVs, in particular, are released from the external membrane of many,
if not all, cell types. These MVs bear surface molecules of their parent
cells that allow them to be targeted to recipient cells, thereby establish-
ing a complex cross-talking network (Tkach and Thery, 2016). The
presence of parent cell membrane proteins in MVs that are released to
the plasma also permits characterization of their cellular origin (e.g., by
ﬂow cytometry). For clarity, in this paper, we will exclusively refer to
EVs as the sum of MVs and exosomes, to MVs for those EVs that are
shed from the plasma membrane and can be quantiﬁed by ﬂow
cytometry (usually with a size > 130 nm) and to exosomes as EVs
released from the endosomal system (usually with a size ≤130 nm).
Recent research ﬁndings suggest that increased body mass index
(BMI) could be a susceptibility factor for the adverse eﬀects of PM
exposure. Increased susceptibility may be partially due to an increase
in particle absorption: BMI was in fact associated with a graded
increase in the estimated total lung dose of deposited ﬁne particles in
an inhalation study of healthy children aged 6–13 years (Bennett and
Zeman, 2004). Moreover, overweight subjects are characterized by a
low-grade systemic inﬂammatory state and adipose tissue dysfunction
(Mraz and Haluzik, 2014). Increased weight is known to increase cell
activation, favoring MV formation (Goichot et al., 2006). At the
molecular level, obesity-related pathogenic factors causing adipocyte
dysfunction include lipid and adipokine dysregulation, mitochondrial
malfunction, and induction of cellular oxidative stress processes
(Hotamisligil, 2010; Diaz-Ruiz et al., 2015). Taken together, these
ﬁndings suggest that BMI may be an important eﬀect modiﬁer when
investigating PM-mediated biological eﬀects and related pathogenic
mechanisms.
Our hypothesis was that EVs produced by the respiratory system
(Kesimer et al., 2009) can be disseminated through the bloodstream
(Orozco and Lewis, 2010) and can play a role in the complex pathway
leading to an increased f CVD risk (Bollati et al., 2015). Therefore, we
evaluated EV release, both quantitatively (i.e., total number and size)
and qualitatively (i.e., characterizing vesicles by their speciﬁc cellular
origin), in volunteers with a measured exposure to size-fractionated
urban PM assessed by both personal sampling with gravimetric
analysis and background ambient monitoring stations, during a 24-h
period before plasma collection. In addition, we stratiﬁed subjects
according to their BMI to determine whether being overweight
increases susceptibility to PM-induced adverse eﬀects.
2. Methods
2.1. Study subjects
We recruited 51 healthy volunteers who answered an ad hoc
developed announcement posted on the SPHERE Project website
(http://users.unimi.it/sphere). After signing a detailed informed
consent form, each subject was asked to wear a miniaturized
personal sampling device to measure PM ≤10 µm and PM ≤2.5 µm
(PM10 and PM2.5) during a 24-h period, beginning at 9 a.m. (day 1). On
the following day, each subject underwent venous blood drawing at 9 a.
m. (day 2) and returned the sampling device to the study team. All
subjects also completed a questionnaire collecting detailed personal
data, including anthropometric characteristics (e.g., height and
weight), education, area of residence, job position and location, time
spent commuting in traﬃc, alcohol consumption, smoking habits,
drugs, and pre-existing medical conditions. Subjects were recruited
from November 2014 to March 2015, a period of the year characterized
by high levels of air pollution in Northern Italy due to mainly traﬃc
exhaust emissions and residential heating combined with peculiar
meteorological phenomena, such as thermal inversion (Carugno
et al., 2016). During the 24-h personal sampling period, subjects
were invited to perform their routine occupational and leisure activities
and continue their voluntary habits.
2.2. Exposure assessment and validation
The subjects’ personal exposure to PM10 and PM2.5 was measured
with a miniaturized personal cascade impactor sampler (PCIS; SKC
Inc., Eighty Four, PA, USA). The sampler consisted of four impaction
stages with cut-oﬀ diameters of 2.5, 1.0, 0.5, and 0.25 µm followed by a
backup ﬁlter stage for particles < 0.25 µm. Stretch polytetraﬂuoroethy-
lene/polytetraﬂuoroethylene (S-PTFE/PTFE) ﬁlters (25 mm diameter
and 0.8 µm porosity) were used as impaction substrates, and the
backup ﬁlters were PTFE w/polymethylpentene ring membranes
(37 mm diameter and 2 µm porosity). For this study, the original
sampler was modiﬁed by excluding the 1.0, 0.5, and 0.25 impaction
stages. A ﬁeld intercomparison test was performed to verify the
agreement between the original and the modiﬁed conﬁguration. The
resulting mean relative error was < 1%.
PM concentrations were determined by gravimetric analysis. The
net PM mass was obtained by weighing ﬁlters before and after
sampling with a microbalance (Micro 1000; Gibertini, Novate, MI,
Italy) inside a temperature- and relative humidity-controlled (20 ±
1 °C, 50 ± 5%) cabinet (Activa Climatic; Aquaria, Lacchiarella, MI,
Italy). Quality of the weighing procedure was assessed using the
American Society of Testing and Materials D 6552 method. The limit
of detection was 9 µg and 5 µg for PM10 and PM2.5, respectively, which
approximately corresponds to 0.7 µg/m3 and 0.4 µg/m3, respectively,
for 24-h samplings at 9 L/min. The PM sampler was connected to a
sampling pump (Leland Legacy; SKC Inc.) operated at a ﬂow rate of
9 L/min and carried by subjects in the breathing zone. During night
time, the instruments were placed in the living room. Ambient
concentrations of PM10 and PM2.5 were also obtained from the regional
air quality monitoring network (ARPA). Average PM10 and PM2.5
levels, calculated based on measurements from the three stations
located in downtown Milan, were selected as suitable estimates of
PM air concentrations in the study area, as the majority of study
subjects resided and/or worked in Milan. Thus, these PM10 and PM2.5
estimates represented the contribution of outdoor contamination to
personal PM exposure. PM levels measured by air monitoring stations
were then compared with the results from PCIS.
2.3. Blood collection and EV isolation
Blood was collected in EDTA tubes and processed within 2 h of the
phlebotomy. EDTA-treated blood was centrifuged at 1200×g for
15 min at room temperature to obtain platelet-free blood plasma.
Plasma was further centrifuged at 1000, 2000, and 3000×g for 15 min
at 4 °C, and the resulting pellet of cell debris was discarded. To prepare
EV pellets for Nanosight analysis and ﬂow cytometry, 1.5 mL of fresh
plasma was transferred to an ultracentrifuge tube (Quick-Seal, Round-
Top, polypropylene, 13.5 mL; Beckman Coulter, Inc., Indianapolis, IN,
USA), which was then ﬁlled up with phosphate-buﬀered saline (PBS)
previously passed 3× through a sterile membrane ﬁlter unit (Stericup-
VP, 0.10 µm, polyethersulfone; EMD Millipore, Billerica, MA, USA) to
minimize contribution of interfering background particles. Plasma was
then spun in a benchtop ultracentrifuge (Optima MAX-XP; Beckman
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Coulter, Inc.) at 110,000×g for 75 min at 4 °C, to obtain an EV-rich
pellet. The pellet was resuspended with 500 µL of triple membrane
0.1 µm ﬁltered PBS for further analysis.
2.4. Nanosight analysis
The number and dimension of EVs were assessed by nanoparticle
tracking analysis (NTA). This technique measures the Brownian
motion of vesicles suspended in a ﬂuid and displays them in real time
through a charge-coupled device camera with high sensitivity. The
Nanosight LM10-HS system (NanoSight Ltd., Amesbury, UK), was
used to visualize the EVs by laser light scattering. Five 30-sec
recordings were performed for each sample. Collected data were
analyzed with NTA software, which provided high-resolution particle
size distribution proﬁles and EV concentration measurements. EVs
were expressed as 106 for 1 ml of plasma, and classiﬁed as total (size:
30–700 nm), exosomes (size: 30–130 nm), and MVs (size: 131–
700 nm).
2.5. Flow cytometry
EVs were characterized with the MACSQuant Analyzer ﬂow cyt-
ometer (Miltenyi Biotec, Calderara di Reno, BO, Italy) according to a
customer-provided protocol (https://goo.gl/8un69P). The Fluoresbrite
Carboxylate Size Range Kit I (0.2, 0.5, 0.75, and 1 µm) was used to set
the calibration gate on the MACSQuant Analyzer system. To evaluate
EV integrity, 60-µL sample aliquots were stained with 0.02 µM 5(6)-
carboxyﬂuorescein diacetate N-succinimidyl ester (CFSE) at 37 °C for
20 min in the dark (Pospichalova et al., 2015). CFSE is a vital dye non
ﬂuorescent molecule, able to enter into MV, where intracellular
esterases remove the acetate group and convert the molecule into the
ﬂuorescent ester form. Each aliquot of CFSE-stained sample was then
incubated with a speciﬁc antibody: CD14-APC (Clone TÜK4) to
distinguish MVs from macrophages and/or monocytes, CD105-APC
(clone: 43A4E1) to distinguish MVs from endothelial cells, CD326
(EpCAM)-APC (clone: HEA-125) to distinguish MVs from epithelial
cells, CD66abce-FITC (clone: TET2) to distinguish MVs from
neutrophils, and CD61-APC (clone: Y2/51) to distinguish MVs from
platelets. All antibodies were purchased from Miltenyi Biotec. Before
use, each antibody was centrifuged at 17,000×g for 30 min at 4 °C to
eliminate aggregates. A stained PBS (control) sample was used to
detect autoﬂuorescence of the antibody. Quantitative multiparameter
analysis of ﬂow cytometry data (expressed as 103 for 1 ml of plasma)
was carried out using FlowJo software (Tree Star, Inc., Ashland, OR,
USA).
2.6. Statistical analysis
Personal and lifestyle characteristics of enrolled subjects were
expressed as mean ± SD for continuous variables and percentages for
categorical variables. Exposure data and EV counts exhibited a non-
normal distribution and were therefore expressed as the median, range,
and interquartile range (IQR). PM10 and PM2.5 exposure data mea-
sured by PCIS were cross-validated with the ARPA data (representing
the average background PM levels in downtown Milan) by Wilcoxon
signed-rank test and Spearman rank correlation (r) analysis.
Before applying linear regression models, exposure data were log
(base 10) transformed to approximate linearity, and MV counts were
log (base e) transformed to achieve a normal distribution. Eﬀects were
thus expressed as the geometric mean ratio (GMR) with 95% con-
ﬁdence interval (CI), which corresponds to the exponential of the β
regression coeﬃcient when the dependent variable is on the log-scale.
GMR indicates the number of times the EV count changes for a 10
times (log10 unit) increase in PM concentration (as measured by PCIS).
Regression models were adjusted for age (continuous data), gender,
BMI (continuous data), and smoking habits (categories: never, former,
and current smoker). To evaluate the possible eﬀect modiﬁcation of
BMI, subjects were stratiﬁed according to the standard CDC deﬁnition
of overweight subjects (BMI < or ≥25 kg/m2) and two separate linear
regression models (adjusted for age, gender and smoking) were run.
Interaction was tested by adding an interaction variable (categorical
BMI:log10 PM exposure) to the multivariate regression model. A p-
value ≤0.05 was considered as statistically signiﬁcant (two-tailed). Data
analysis was performed using SAS (version 9.3; SAS Institute Inc.,
Cary, NC, USA) and Stata (version 13; StataCorp, College Station, TX,
USA).
3. Results
The main characteristics of the study subjects are reported in
Table 1. Females comprised 58.8% of subjects, with a mean age of 48.7
± 8.4 years (range: 38–73). Mean BMI was 24.4 ± 3.2 kg/m2 (range:
19–30), with 24 subjects classiﬁed as overweight. Most of the subjects
were never smokers (54.9%), had a university degree (62.7%), and
were currently employed (94.1%). Almost half of the study participants
lived in Milan. Another 27% lived in the province of Milan, and almost
all worked within the city.
As shown in Fig. 1, median PM10 and PM2.5 exposure levels
measured by ambient monitoring stations did not diﬀer from those
measured by PCIS (PM10: 46.8 µg/m
3 vs. 45.1 µg/m3, respectively;
PM2.5: 34.0 µg/m
3 vs. 36.1 µg/m3, respectively; Wilcoxon test for
equality of medians: p = 0.28 for PM10 and p = 0.48 for PM2.5), and
they were signiﬁcantly correlated (PM10: Spearman's r = 0.59; PM2.5:
r = 0.68; both p < 0.001). At the same time, PM10 and PM2.5 levels from
PCIS resulted highly correlated (r = 0.97; p < 0.001).
EV counts quantiﬁed by Nanosight analysis and characterized by
ﬂow cytometry are shown in Table 2. Median count of total EVs was
Table 1
Demographic and lifestyle characteristics of study participants (n = 51).
Characteristic N (%)
Age, years
Mean, ± SD 48.7, ± 8.4
< 40 4 (7.8)
40–44 18 (35.3)
45–49 10 (19.6)
50–54 7 (13.7)
55+ 12 (23.5)
Gender
Male 21 (41.2)
Female 30 (58.8)
Body Mass Index, Kg/m2
Mean, ± SD 24.4, ± 3.2
< 25 25 (49.0)
≥25 24 (47.1)
Missing 2 (3.9)
Smoking habit
Never smoker 28 (54.9)
Former smoker 13 (25.5)
Current smoker 10 (19.6)
Education
University 32 (62.7)
High school 13 (25.5)
Other 6 (11.8)
Occupation
Currently employed 48 (94.1)
Retired 3 (5.9)
Living area
City of Milan 24 (47.1)
Province of Milan, outside city area 14 (27.4)
Province of Monza-Brianza 7 (13.7)
Other provinces in Lombardy 6 (11.8)
Work area
City of Milan 43 (84.4)
Other 4 (7.8)
Unknown 4 (7.8)
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1838.6×106/ml PL, which included a larger fraction of MVs (median
=1558.8×106/ml PL) relative to that of the smaller-sized exosomes
(median=281.4×106/ml PL). As for cellular origin by ﬂow cytometry,
the larger MV fraction originated from platelets (CD61+). Smaller
proportions of MVs derived from neutrophils (CD66+), macrophages/
monocytes (CD14+), and epithelial (EpCAM+) and endothelial
(CD105+) cells were also identiﬁed.
Neither univariate nor multivariate regression analysis in the whole
population (Table 3) revealed a clear pattern of association between EV
count and PM exposure. However, multivariate analysis revealed a PM-
related increase of MVs derived from the endothelium (PM10: adjusted
GMR = 3.47; 95% CI: 1.30, 9.27; p = 0.01; PM2.5: adjusted GMR = 3.14;
95% CI: 1.23, 8.02; p = 0.02) and from macrophages/monocytes (PM10:
adjusted GMR = 3.45; 95% CI: 1.00, 11.94; p = 0.05; PM2.5: adjusted
GMR = 3.70; 95% CI: 1.16, 11.86; p = 0.03). After stratifying by BMI
(Table 4), no association between PM exposure and EV total count (in
details total EV, exosomes and MV) was found in either normal or
overweight subjects. Compared to that in normal subjects, the overweight
subjects showed a much more pronounced PM-related eﬀect among MVs
derived from all cellular subtypes; however, this eﬀect was particularly
strong for MVs of endothelial origin, with approximately a 6× increase in
MVs for each log10 unit increase in PM exposure (PM10: GMR = 6.68; 95%
CI: 2.29, 19.49; p = 0.002; PM2.5: GMR = 5.79; 95% CI: 1.98, 16.89; p =
0.003) (Table 4 and Fig. 2). Interaction tests were formally performed to
assess eﬀect modiﬁcation between BMI and PM exposure (see Table 4, last
column to the right) and were statistically, or borderline statistically
signiﬁcant for all the considered cellular origins except for macrophages/
monocytes, indicating a sensibly larger PM eﬀect among overweight
subjects.
4. Discussion
In this study, we observed that exposure of healthy volunteers to
PM10 and PM2.5 over a 24-h period can modulate release of EVs,
particularly those of endothelial origin. The association resulted mainly
attributable to overweight subjects. To our knowledge, this is the ﬁrst
study that has investigated the association between short-term PM
exposure and EV release in humans.
The importance of PM-related EV increase has been recently
addressed by Rodosthenous et al. (2016), who found an association
between ambient PM2.5 levels and increased levels of EV-encapsulated
microRNAs (EV-miRNAs) among 22 older individuals randomly
selected from the Normative Aging Study in the greater Boston area.
As this study was conducted on frozen samples, a precise counting of
EVs and determination of their cellular origin was not feasible. Hence,
the authors acknowledged that the observed overall increase in blood
EV-miRNA levels may have originated either from an increase in
numbers of EV released by blood cells or tissues sensitive to air
pollution or from an increase in the amount of speciﬁc miRNAs loaded
into EVs prior to their release into the circulation. With the ability to
analyze fresh samples, we had the opportunity in the present study to
analyze EV count and MV cellular origin by contemporary methods
(i.e., Nanosight and ﬂow cytometry, respectively). These methods
allowed us to better describe a complex systemic phenomenon invol-
ving EV release in response to proinﬂammatory stimuli.
Concordant results were observed in our previous study of foundry
workers exposed to metal-rich PM, which revealed alterations in EV-
miRNA levels in response to short-term PM exposure (Bollati et al.,
2015). Interestingly, previous studies have shown that elevated num-
bers of EVs in healthy subjects are linked to increased risk of
developing CVD (Chironi et al., 2006; Ueba et al., 2010) and that
EVs likely act as powerful intercellular messengers in the pathogenesis
of CVD (Loyer et al., 2014). Although we did not present any
cardiovascular or, more in general, clinical outcome, we believe that,
together with the above mentioned studies, our study can support the
hypothesis that EVs release (from endothelium, in particular) could
represent a molecular mechanism involved in mediating short-term
systemic response to PM exposures.
Considering the entire study population, we observed an eﬀect of
PM2.5 and PM10 exposure on monocyte/macrophage EV release.
Alveolar macrophages represent one of the ﬁrst target of PM action,
as a direct uptake of PM by phagocytes, such as by macrophages, has
been demonstrated (Hiraiwa and van Eeden, 2013).
Our ﬁndings are even more interesting in light of the fact that one of
the most important gaps in our current knowledge regarding PM-
related health eﬀects is the identiﬁcation of susceptible subjects (Chen
et al., 2007). Although they are based on a relatively small study
population, our results suggest that the PM eﬀect is considerably more
pronounced among individuals with a BMI > 25 kg/m2 (i.e., the over-
weight group). As a potentially critical factor of susceptibility to PM
Fig. 1. Box plots summarizing the exposure levels to PM10 (grey) and PM2.5 (red)
measured by Personal Cascade Impactor Samplers (PCIS) and Ambient Monitoring
Stations (AMS) (For interpretation of the references to color in this ﬁgure legend, the
reader is referred to the web version of this article.).
Table 2
Quantification of EV fractions and MV subtypes.
Exosomes and MV characteristics Median (Q1-Q3) Range
EV counta (106/ml PL) Total EV (Exosomes + MV) 1838.6 (1566.0–2321.6) 944.4–3255.0
Exosomes 281.4 (164.7–367.8) 55.2–818.1
MV 1558.8 (1338.5–2030.4) 889.2–2870.5
MV subtypesb (103/ml PL) MV CD61+ (platelets) 264.1 (115.4–411.7) 39.9–1427.7
MV CD66+ (neutrophils) 7.8 (4.4–15.2) 2.0–40.4
MV EpCAM+ (epithelium) 11.5 (7.0–15.7) 3.0–41.9
MV CD105+ (endothelium) 10.9 (6.7–19.9) 2.5–38.2
MV CD14+ (macrophages/ monocytes) 13.8 (8.0–27.8) 2.9–113.5
Q1–Q3, first quartile –third quartile.
a Counts of EV fractions obtained by Nanosight analysis.
b Counts of MV subtypes obtained by ﬂow cytometry.
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eﬀects, BMI should be carefully considered in all studies that investigate
the biological role of EVs. Being overweight, as well as obesity, is a very
common condition, the prevalence of which is increasing worldwide and
which represents a major public health issue (Ahima, 2011). Adipose
tissue appears to play a role in development of the proinﬂammatory state
and in shifting the redox balance toward a more oxidative state.
Therefore, it is reasonable to speculate that subjects with unbalanced
or altered redox signaling could be particularly susceptible to PM-related
health eﬀects as a result of dysregulation of the pathways that link
particle exposure to systemic manifestations.
It has been shown that PM can produce oxidative stress in both in
vitro and in vivo systems, and we have recently observed a strong
increase in oxidative stress markers associated with exposure to high
metal-rich PM levels in aﬀected workers (Bertazzi et al., 2014). It is
Table 3
Association between PM exposure (data from personal sampler) and different classes of Extracellular Vesicles (EV). Linear regression models after log transformation of both PM
exposure and outcomes.
PM10 from personal samplers PM2.5 from personal samplers
Univariate regression Multivariate regressiona Univariate regression Multivariate regressiona
Exosomes and MV characteristics GMR (95% CI) p GMR (95% CI) p GMR (95% CI) p GMR (95% CI) p
EV countb (106/ml
PL)
Total EV 1.13 (0.76,
1.69)
0.53 1.05 (0.7, 1.57) 0.83 1.17 (0.81,
1.69)
0.39 1.05 (0.72, 1.55) 0.78
Exosomes 0.89 (0.38, 2.1) 0.79 0.60 (0.26,
1.39)
0.23 0.97 (0.44,
2.13)
0.93 0.58 (0.26, 1.29) 0.18
MV 1.21 (0.83,
1.75)
0.31 1.18 (0.8, 1.75) 0.40 1.24 (0.88,
1.74)
0.22 1.20 (0.83, 1.74) 0.33
MV subtypesc (103/
ml PL)
MV CD61+ (platelets) 1.58 (0.43,
5.78)
0.48 1.49 (0.35,
6.33)
0.58 1.62 (0.49,
5.34)
0.42 1.52 (0.39, 5.98) 0.54
MV CD66+
(neutrophils)
1.56 (0.49,
5.00)
0.45 1.89 (0.54,
6.61)
0.31 1.55 (0.53,
4.53)
0.42 1.91 (0.58, 6.24) 0.28
MV EpCAM+
(epithelium)
1.64 (0.68,
3.95)
0.26 1.86 (0.71,
4.91)
0.20 1.47 (0.65,
3.32)
0.34 1.67 (0.66, 4.21) 0.27
MV CD105+
(endothelium)
3.10 (1.29,
7.46)
0.01 3.47 (1.3, 9.27) 0.01 2.88 (1.28,
6.45)
0.01 3.14 (1.23, 8.02) 0.02
MV CD14+ (macr./
monoc.)
2.54 (0.82, 7.9) 0.11 3.45 (1, 11.94) 0.05 2.49 (0.88,
7.06)
0.09 3.70 (1.16,
11.86)
0.03
GMR, Geometric Mean Ratio.
a Linear regression model adjusted for age, gender, BMI, and smoking habit (never, former, current smoker); PM10/PM2.5 values missing for 1 record.
b Counts of EV fractions obtained by Nanosight analysis.
c Counts of MV subtypes obtained by ﬂow cytometry.
Table 4
Association between PM exposure and different classes of EV, stratifying subjects by BMI ( < vs ≥25 kg/m2). Results from a multivariate regression models adjusted for age, gender and
smoking habit (PM10/PM2.5 values missing for 1 record, BMI values missing for 2 records).
BMI <25 (n=25) BMI ≥25 (n =23)
GMR (95% CI) p GMR (95% CI) p p for interaction
PM10 exposure
EV counta (106/ml PL) Total EV 1.11 (0.37, 3.37) 0.85 1.25 (0.68, 2.30) 0.45 0.43
Exosomes 1.31 (0.08, 22.19) 0.85 0.81 (0.28, 2.29) 0.67 0.93
MV 1.15 (0.43, 3.10) 0.77 1.36 (0.74, 2.51) 0.30 0.41
MV subtypesb (103/ml PL) MV CD61+ (platelets) 0.04 (0.00, 1.62) 0.09 5.93 (0.77, 45.63) 0.08 0.01
MV CD66+ (neutrophils) 0.19 (0.01, 7.10) 0.35 3.91 (0.80, 19.08) 0.09 0.04
MV EpCAM+ (epithelium) 0.16 (0.01, 2.53) 0.18 3.36 (0.97, 0.97) 0.06 0.02
MV CD105+ (endothelium) 0.34 (0.01, 8.15) 0.49 6.68 (2.29, 19.49) 0.002 0.03
MV CD14+ (macr./monoc.) 0.74 (0.01, 51.76) 0.88 3.23 (0.93, 11.24) 0.06 0.47
PM2.5 exposure
EV counta (106/ml PL) Total EV 1.10 (0.44, 2.74) 0.83 1.28 (0.71, 2.29) 0.39 0.44
Exosomes 1.15 (0.11, 11.72) 0.90 0.81 (0.30, 2.23) 0.67 0.99
MV 1.17 (0.52, 2.64) 0.69 1.39 (0.77, 2.51) 0.25 0.42
MV subtypesb (103/ml PL) MV CD61+ (platelets) 0.16 (0.01, 3.79) 0.24 5.62 (0.78, 40.40) 0.08 0.02
MV CD66+ (neutrophils) 0.41 (0.02, 8.24) 0.54 3.66 (0.79, 17.01) 0.09 0.07
MV EpCAM+ (epithelium) 0.30 (0.03, 3.09) 0.30 2.77 (0.80, 9.57) 0.10 0.05
MV CD105+ (endothelium) 0.69 (0.05, 9.53) 0.77 5.79 (1.98, 16.89) 0.003 0.06
MV CD14+ (macr./monoc.) 1.50 (0.05, 48.64) 0.81 3.32 (1.01, 10.88) 0.05 0.56
GMR, Geometric Mean Ratio.
a Counts of EV fractions obtained by Nanosight analysis.
b Counts of MV subtypes obtained by ﬂow cytometry.
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worth noting that the role of MVs in redox signaling has been regarded
as a very promising area of investigation, as recently reviewed by
Larson and collaborators (Larson et al., 2014). According to our data,
the most pronounced PM eﬀect was observed in endothelial MVs. The
endothelium is a well-known homeostatic organ that is essential for the
regulation of vascular tone and structure (Versari et al., 2009). Under
physiological conditions, stimulation of the endothelium leads to
production and release of nitric oxide, which diﬀuses to surrounding
tissue and cells and exerts its cardiovascular protective eﬀects by
relaxing media-smooth muscle cells and thus preventing leukocyte
adhesion and migration into the arterial wall, muscle cell proliferation,
platelet adhesion and aggregation, and adhesion molecule expression
(Taddei et al., 2003). In the presence of cardiovascular risk factors
during the earliest stages of the disease process, the endothelium
undergoes functional and structural alterations (Taddei et al., 2003).
Given this scenario, the observed increase of endothelial MVs following
exposure to a cardiovascular risk factor (i.e., PM exposure) might be
biologically relevant. Moreover, after deposition on alveolar epithe-
lium, naïve PM or modiﬁed PM following macrophage phagocytosis
can pass through the alveolar-capillary membrane and directly interact
with pulmonary endothelium (Tamagawa et al., 2008), which may
become a direct target for PM eﬀects. As previously described in
Northern Italian environmental studies, our subjects were exposed to
quite a large range of PM levels, allowing us to investigate biological
eﬀects across a wider PM exposure range and at higher PM concentra-
tions compared to those measured in previous investigations
(Rodosthenous et al., 2016).
In our study, individual PM exposure was assessed using the PCIS
that allowed us to take into better consideration the personal factors
that may produce individual variability, such as indoor exposures,
traﬃc exposure, etc. However, the PCIS was worn for only 24 h. We
focused on short-term PM exposure because it has a greater biological
eﬀect on EV release. Eﬀects from short-term exposure are quick and
rapidly changing, and, unlike those from chronic exposure, they are not
responsive to inherent adaptive mechanisms. We also based our
analyses on data from the PCIS rather than from the ambient
monitoring stations in order to minimize exposure misclassiﬁcations.
It is remarkable that we observed a strong association between PM
levels measured by PCIS and PM level estimates based on average
measurements from ambient monitoring stations located in downtown
Milan. This ﬁnding suggests the possibility that PCIS data could be
reasonably integrated with exposure estimates based on air monitoring
stations in order to investigate larger populations or to evaluate PM
exposure over a more extended period of time.
We obtained our results from only 51 healthy subjects, which
consequently yielded low statistical power. The size of the observed
eﬀects makes us conﬁdent that these changes in EV release are not due
to chance, but one must be very cautious in generalizing our results to
the larger Italian population with diﬀerent characteristics and/or
exposure conditions. We observed an enhanced eﬀect among over-
weight subjects, which supports the biological plausibility of an
increased susceptibility to PM in subjects with higher BMIs.
However, a limitation of this study was that our investigation was
limited to overweight subjects, as we did not investigate obese or
severely obese subjects. Finally, it may be possible that other condi-
tions strictly correlated to elevated BMI, such as unbalanced diet or
sedentary habits, may explain the observed increase in EV release in
response to PM exposure.
5. Conclusions
Our ﬁndings show that EV release is associated with short-term PM
Fig. 2. Association between MV from endothelium (CD105+) and PM exposure measured by personal samplers. Scatterplots of MV (103/ml PL) versus PM10 (above) or PM2.5 (below)
levels (µg/m3), in subjects with BMI < 25 (left) or ≥25 (right) kg/m2. Covariate-adjusted Geometric Mean Ratios and corresponding 95% Conﬁdence Intervals [GMR (95%CI)] in MV
estimated per log10-unit increase in PM are shown.
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exposure and that overweight subjects are potentially more susceptible
to EV release in response to this exposure. Larger studies that include
accurate exposure assessment and complete EV characterization, as
well as a detailed analysis of EV content, could better clarify the
molecular mechanism responsible for the PM eﬀects. Such studies
could also further elucidate the underlying mechanism responsible for
increased susceptibility to PM eﬀects that appears to be evident in
overweight and/or obese subjects, which likely represent a more
susceptible population in terms of PM-induced EV release and air
pollution-related health eﬀects. If conﬁrmed, these ﬁndings could help
elucidate the subclinical biological changes that precede the onset of air
pollution-associated diseases. Moreover, they could help us to identify
susceptible subjects and develop new preventive policies for the
promotion of public health.
Ethics approval and consent to participate
Each participant signed a written informed consent, approved by
the Ethic Committee of the Fondazione Ca’Granda – Ospedale
Maggiore Policlinico (approval number 1425), in accordance with the
Helsinki Declaration principles.
Consent for publication
Not applicable.
Availability of data and material
Please contact corresponding author for data request.
Competing interests
The authors declare that they have no competing interests.
Funding
This project received support from the EU Programme “Ideas”
(ERC-2011-StG 282413), principal investigator Prof. Valentina Bollati.
Acknowledgements
We thank the Occupational Medicine Medical Residents for their
help in examining and recruiting the study subjects. We are grateful to
the nurses of the “Medicina del Lavoro” Unit, Fondazione IRCCS Ca’
Granda Ospedale Maggiore Policlinico, Enrico Radice for database
development, Elisabetta Angiolino from Regional Environmental
Protection Agency (ARPA), as well as the volunteers who participated
in the study.
Appendix A. Supporting information
Supplementary data associated with this article can be found in the
online version at doi:10.1016/j.envres.2017.02.014.
References
Ahima, R.S., 2011. Digging deeper into obesity. J. Clin. Investig. 121 (6), 2076–2079.
Bennett, W.D., Zeman, K.L., 2004. Eﬀect of body size on breathing pattern and ﬁne-
particle deposition in children. J. Appl. Physiol. 97 (3), 821–826.
Bertazzi, P.A., Cantone, L., Pignatelli, P., Angelici, L., Bollati, V., Bonzini, M., et al., 2014.
Does enhancement of oxidative stress markers mediate health eﬀects of ambient air
particles? Antioxid. Redox Signal. 21 (1), 46–51.
Bollati, V., Angelici, L., Rizzo, G., Pergoli, L., Rota, F., Hoxha, M., et al., 2015.
Microvesicle-associated microRNA expression is altered upon particulate matter
exposure in healthy workers and in A549 cells. J. Appl. Toxicol. 35 (1), 59–67.
Carugno, M., Consonni, D., Randi, G., Catelan, D., Grisotto, L., Bertazzi, P.A., et al., 2016.
Air pollution exposure, cause-speciﬁc deaths and hospitalizations in a highly polluted
Italian region. Environ. Res. 147, 415–424.
Chen, J.C., Cavallari, J.M., Stone, P.H., Christiani, D.C., 2007. Obesity is a modiﬁer of
autonomic cardiac responses to ﬁne metal particulates. Environ. Health Perspect.
115 (7), 1002–1006.
Chironi, G., Simon, A., Hugel, B., Del Pino, M., Gariepy, J., Freyssinet, J.M., et al., 2006.
Circulating leukocyte-derived microparticles predict subclinical atherosclerosis
burden in asymptomatic subjects. Arterioscler. Thromb. Vasc. Biol. 26 (12),
2775–2780.
Diaz-Ruiz, A., Guzman-Ruiz, R., Moreno, N.R., Garcia-Rios, A., Delgado-Casado, N.,
Membrives, A., et al., 2015. Proteasome dysfunction associated to oxidative stress
and proteotoxicity in adipocytes compromises insulin sensitivity in human obesity.
Antioxid. Redox Signal. 23 (7), 597–612.
Goichot, B., Grunebaum, L., Desprez, D., Vinzio, S., Meyer, L., Schlienger, J.L., et al.,
2006. Circulating procoagulant microparticles in obesity. Diabetes Metab. 32 (1),
82–85.
Hiraiwa, K., van Eeden, S.F., 2013. Contribution of lung macrophages to the
inﬂammatory responses induced by exposure to air pollutants. Mediat. Inﬂamm.
2013, 619523.
Hotamisligil, G.S., 2010. Endoplasmic reticulum stress and the inﬂammatory basis of
metabolic disease. Cell 140 (6), 900–917.
Hunter, M.P., Ismail, N., Zhang, X., Aguda, B.D., Lee, E.J., Yu, L., et al., 2008. Detection
of microRNA expression in human peripheral blood microvesicles. PloS One 3 (11),
e3694.
Johnson, B.L., Iii, Kuethe, J.W., Caldwell, C.C., 2014. Neutrophil derived microvesicles:
emerging role of a key mediator to the immune response. Endocr. Metab. Immune
Disord. Drug Targets 14 (3), 210–217.
Jungel, A., Distler, O., Schulze-Horsel, U., Huber, L.C., Ha, H.R., Simmen, B., et al.,
2007. Microparticles stimulate the synthesis of prostaglandin E(2) via induction of
cyclooxygenase 2 and microsomal prostaglandin E synthase 1. Arthritis Rheum. 56
(11), 3564–3574.
Katsouyanni, K., Touloumi, G., Samoli, E., Gryparis, A., Le Tertre, A., Monopolis, Y.,
et al., 2001. Confounding and eﬀect modiﬁcation in the short-term eﬀects of ambient
particles on total mortality: results from 29 European cities within the APHEA2
project. Epidemiology 12 (5), 521–531.
Kesimer, M., Scull, M., Brighton, B., DeMaria, G., Burns, K., O'Neal, W., et al., 2009.
Characterization of exosome-like vesicles released from human tracheobronchial
ciliated epithelium: a possible role in innate defense. FASEB J. 23 (6), 1858–1868.
Kinney, P.L., Ozkaynak, H., 1991. Associations of daily mortality and air pollution in Los
Angeles County. Environ. Res. 54 (2), 99–120.
Larson, M.C., Hillery, C.A., Hogg, N., 2014. Circulating membrane-derived microvesicles
in redox biology. Free Radic. Biol. Med. 73, 214–228.
Leroyer, A.S., Tedgui, A., Boulanger, C.M., 2008. Role of microparticles in
atherothrombosis. J. Intern. Med. 263 (5), 528–537.
Loyer, X., Vion, A.C., Tedgui, A., Boulanger, C.M., 2014. Microvesicles as cell-cell
messengers in cardiovascular diseases. Circ. Res. 114 (2), 345–353.
Mraz, M., Haluzik, M., 2014. The role of adipose tissue immune cells in obesity and low-
grade inﬂammation. J. Endocrinol. 222 (3), R113–R127.
Orozco, A.F., Lewis, D.E., 2010. Flow cytometric analysis of circulating microparticles in
plasma. Cytom. Part A: J. Int. Soc. Anal. Cytol. 77 (6), 502–514.
Pospichalova, V., Svoboda, J., Dave, Z., Kotrbova, A., Kaiser, K., et al., 2015. Simpliﬁed
protocol for ﬂow cytometry analysis of ﬂuorescently labeled exosomes and
microvesicles using dedicated ﬂow cytometer. J. Extracell Vesicles 31, 25530.
Prakash, P.S., Caldwell, C.C., Lentsch, A.B., Pritts, T.A., Robinson, B.R., 2012. Human
microparticles generated during sepsis in patients with critical illness are neutrophil-
derived and modulate the immune response. J. Trauma Acute Care Surg. 73 (2),
401–406, (discussion 406-407).
Raposo, G., Stoorvogel, W., 2013. Extracellular vesicles: exosomes, microvesicles, and
friends. J. Cell Biol. 200 (4), 373–383.
Rautou, P.E., Vion, A.C., Amabile, N., Chironi, G., Simon, A., Tedgui, A., et al., 2011.
Microparticles, vascular function, and atherothrombosis. Circ. Res. 109 (5),
593–606.
Rodosthenous, R.S., Coull, B.A., Lu, Q., Vokonas, P.S., Schwartz, J.D., Baccarelli, A.A.,
2016. Ambient particulate matter and microRNAs in extracellular vesicles: a pilot
study of older individuals. Part. Fibre Toxicol. 13, 13.
Schwartz, J., Dockery, D.W., 1992. Increased mortality in Philadelphia associated with
daily air pollution concentrations. Am. Rev. Respir. Dis. 145 (3), 600–604.
Taddei, S., Ghiadoni, L., Virdis, A., Versari, D., Salvetti, A., 2003. Mechanisms of
endothelial dysfunction: clinical signiﬁcance and preventive non-pharmacological
therapeutic strategies. Curr. Pharm. Des. 9 (29), 2385–2402.
Tamagawa, E., Bai, N., Morimoto, K., Gray, C., Mui, T., Yatera, K., et al., 2008.
Particulate matter exposure induces persistent lung inﬂammation and endothelial
dysfunction. Am. J. Physiol. Lung Cell. Mol. Physiol. 295 (1), L79–L85.
Tkach, M., Thery, C., 2016. Communication by extracellular vesicles: where we are and
where we need to go. Cell 164 (6), 1226–1232.
Ueba, T., Nomura, S., Inami, N., Nishikawa, T., Kajiwara, M., Iwata, R., et al., 2010.
Plasma level of platelet-derived microparticles is associated with coronary heart
disease risk score in healthy men. J. Atheroscler. Thromb. 17 (4), 342–349.
Versari, D., Daghini, E., Virdis, A., Ghiadoni, L., Taddei, S., 2009. Endothelial
dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 32
(Suppl. 2), S314–S321.
M. Bonzini et al. Environmental Research 155 (2017) 228–234
234
